End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
15.55
CNY
|
-2.14%
|
|
+4.22%
|
+5.07%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,807
|
1,946
|
2,022
|
2,205
|
2,165
|
3,310
|
Enterprise Value (EV)
1 |
1,591
|
1,736
|
1,874
|
2,115
|
2,043
|
3,068
|
P/E ratio
|
86
x
|
69.9
x
|
53.1
x
|
47.7
x
|
49.2
x
|
63
x
|
Yield
|
0.36%
|
0.44%
|
0.58%
|
0.64%
|
0.62%
|
0.48%
|
Capitalization / Revenue
|
3.23
x
|
2.95
x
|
2.91
x
|
3.12
x
|
2.94
x
|
3.49
x
|
EV / Revenue
|
2.84
x
|
2.63
x
|
2.69
x
|
2.99
x
|
2.78
x
|
3.23
x
|
EV / EBITDA
|
58.6
x
|
43.5
x
|
43.6
x
|
43.4
x
|
40.7
x
|
53.2
x
|
EV / FCF
|
52.1
x
|
11.2
x
|
-27.9
x
|
29.1
x
|
143
x
|
-677
x
|
FCF Yield
|
1.92%
|
8.91%
|
-3.59%
|
3.43%
|
0.7%
|
-0.15%
|
Price to Book
|
2.39
x
|
2.5
x
|
2.51
x
|
2.63
x
|
2.49
x
|
3.65
x
|
Nbr of stocks (in thousands)
|
223,646
|
223,646
|
223,646
|
223,646
|
223,646
|
223,646
|
Reference price
2 |
8.080
|
8.700
|
9.040
|
9.860
|
9.680
|
14.80
|
Announcement Date
|
3/22/19
|
4/28/20
|
3/26/21
|
3/25/22
|
3/23/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
559.9
|
660.1
|
695.9
|
706.8
|
735.2
|
949.6
|
EBITDA
1 |
27.15
|
39.88
|
43
|
48.77
|
50.25
|
57.64
|
EBIT
1 |
17.13
|
27.79
|
32.71
|
38.61
|
40.44
|
47.99
|
Operating Margin
|
3.06%
|
4.21%
|
4.7%
|
5.46%
|
5.5%
|
5.05%
|
Earnings before Tax (EBT)
1 |
26.96
|
29.66
|
40.98
|
51.35
|
49.76
|
59.14
|
Net income
1 |
21.01
|
27.85
|
38.06
|
46.28
|
44.02
|
52.51
|
Net margin
|
3.75%
|
4.22%
|
5.47%
|
6.55%
|
5.99%
|
5.53%
|
EPS
2 |
0.0939
|
0.1245
|
0.1702
|
0.2069
|
0.1968
|
0.2348
|
Free Cash Flow
1 |
30.53
|
154.7
|
-67.23
|
72.6
|
14.33
|
-4.531
|
FCF margin
|
5.45%
|
23.44%
|
-9.66%
|
10.27%
|
1.95%
|
-0.48%
|
FCF Conversion (EBITDA)
|
112.47%
|
387.95%
|
-
|
148.87%
|
28.51%
|
-
|
FCF Conversion (Net income)
|
145.34%
|
555.51%
|
-
|
156.86%
|
32.55%
|
-
|
Dividend per Share
2 |
0.0290
|
0.0380
|
0.0520
|
0.0630
|
0.0600
|
0.0710
|
Announcement Date
|
3/22/19
|
4/28/20
|
3/26/21
|
3/25/22
|
3/23/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
216
|
210
|
148
|
89.9
|
122
|
242
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
30.5
|
155
|
-67.2
|
72.6
|
14.3
|
-4.53
|
ROE (net income / shareholders' equity)
|
2.99%
|
3.47%
|
4.89%
|
5.67%
|
5.4%
|
5.99%
|
ROA (Net income/ Total Assets)
|
0.65%
|
1.06%
|
1.14%
|
1.22%
|
1.28%
|
1.67%
|
Assets
1 |
3,239
|
2,632
|
3,337
|
3,797
|
3,449
|
3,152
|
Book Value Per Share
2 |
3.390
|
3.480
|
3.600
|
3.750
|
3.880
|
4.060
|
Cash Flow per Share
2 |
0.3300
|
0.2500
|
0.3000
|
0.1900
|
0.2000
|
0.5500
|
Capex
1 |
5.13
|
9.87
|
0.89
|
1.17
|
0.81
|
0.5
|
Capex / Sales
|
0.92%
|
1.49%
|
0.13%
|
0.17%
|
0.11%
|
0.05%
|
Announcement Date
|
3/22/19
|
4/28/20
|
3/26/21
|
3/25/22
|
3/23/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +5.07% | 480M | | +9.12% | 33.76B | | +14.69% | 7.72B | | +3.88% | 7.03B | | +21.31% | 5.36B | | -3.97% | 4.14B | | +38.58% | 4.07B | | +15.15% | 3.77B | | +5.14% | 3.42B | | -9.87% | 2.64B |
Testing & Measuring Equipment
|